Cargando…
Copeptin Levels Are Independent from Mild Therapeutic Hypothermia but Do Not Predict Infarct Size in Patients Presenting with ST-Segment Elevation Myocardial Infarction
Background: Mild therapeutic hypothermia (MTH) is a treatment adjunct in ST-segment elevation myocardial infarction (STEMI) that deserves investigation. Copeptin―a surrogate marker for vasopressin―is an early biomarker in STEMI. Data from cardiac arrest patients suggest a reduction of copeptin level...
Autores principales: | Mueller, Matthias, Beitzke, Dietrich, Scherz, Thomas, Loewe, Christian, Mangold, Andreas, Marculescu, Rodrig, Poppe, Michael, Sterz, Fritz, Herkner, Harald, Lang, Irene, Testori, Christoph, Weiser, Christoph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539262/ https://www.ncbi.nlm.nih.gov/pubmed/34677200 http://dx.doi.org/10.3390/jcdd8100131 |
Ejemplares similares
-
Out-of-hospital initiation of hypothermia in ST-segment elevation myocardial infarction: a randomised trial
por: Testori, Christoph, et al.
Publicado: (2019) -
Mild Therapeutic Hypothermia Alters Hemostasis in ST Elevation Myocardial Infarction Patients
por: Scherz, Thomas, et al.
Publicado: (2021) -
Exploratory echocardiographic strain parameters for the estimation of myocardial infarct size in ST‐elevation myocardial infarction
por: Dannenberg, Varius, et al.
Publicado: (2021) -
Relationship between time to target temperature and outcome in patients treated with therapeutic hypothermia after cardiac arrest
por: Haugk, Moritz, et al.
Publicado: (2011) -
Surface cooling for induction of mild hypothermia in conscious healthy volunteers - a feasibility trial
por: Testori, Christoph, et al.
Publicado: (2011)